Kronox Lab Sciences IPO Review

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

IPO IS THE HITTING THE STREETS NEXT WEEK

KRONOX LAB SCIENCES IPO REVIEW

KRONOX LAB SCIENCES IS LAUNCHING ITS


INITIAL PUBLIC OFFERING (IPO) TO RAISE
CAPITAL FOR ITS GROWTH AND
EXPANSION. BELOW ARE THE KEY DETAILS
AND INSIGHTS.
COMPANY OVERVIEW

Incorporated in 2008, Kronox Lab Sciences


Limited is a manufacturer of high-purity
specialty fine chemicals used across various
industries. These include pharmaceuticals,
scientific research, nutraceuticals, biotech,
agrochemicals, personal care, metal refineries,
and animal health products. The company
offers over 185 products, including phosphate,
sulfate, acetate, chloride, citrate, nitrates,
nitrites, carbonate, EDTA derivatives,
hydroxide, succinate, and gluconate. .
NEW PRODUCTS AND SERVICES

Production Plant Product Category


Global Presence The company operates three manufacturing Kronox Lab Sciences has been
Kronox Lab Sciences exports its facilities in Vadodara, Gujarat, near the seaports actively involved in research and
products to over 20 countries, of Mundra, Kandla, Hazira, and Nhava Sheva. development, with ongoing R&D on
including the United States, These facilities span 17,454 sq. m. and have an 122 products as of December 31,
Argentina, Mexico, Australia, installed capacity of 7,242 TPA as of December 2023. Over the past three years, the
Egypt, Spain, Turkey, the United 31, 2023. The facilities hold multiple company has served more than 592
Kingdom, Belgium, the United certifications, including FSSC 22000, ISO customers, with 141 repeat orders
Arab Emirates, and China. 9001:2015, ISO 14001:2015, ISO 45001:2018, and by the end of 2023. The company
some products are certified Kosher, Halal, GMP, employs 212 people at various
and GLP. levels.
IPO DETAILS

IPO Open Date: Monday, June 3, IPO Close Date: Wednesday, June 5,
2024
2024

Basis of Allotment: Listing Date: Monday,


Thursday, June 6, 2024 June 10, 2024

Price Band: ₹129 to ₹136


Face Value: ₹10 per share per share

Total Issue Size: 9,570,000


Lot Size: 110 shares shares, aggregating up to
₹130.15 Cr

Offer for Sale: 9,570,000 shares Offer for Sale: 9,570,000 shares
of ₹10, aggregating up to of ₹10, aggregating up to
₹130.15 Cr ₹130.15 Cr

Issue Type: Book Built Issue IPO Listing At: BSE, NSE

Shareholding Pre-Issue: Shareholding Post-Issue:


37,104,000 shares 37,104,000 shares
FINANCIAL PERFORMANCE
Kronox Lab Sciences has shown strong financial
performance, with consistent revenue growth and
healthy profit margins. The company's robust balance
sheet is a positive indicator for potential investors.

COMPETITIVE STRENGTHS
1. Diverse Service Portfolio: Offering a wide range of
laboratory services mitigates the risk associated with
dependence on a single service line.
2. Advanced Technology: Investments in cutting-edge
technology ensure high accuracy and efficiency in
testing processes.
3. Experienced Management: Led by industry veterans
with extensive experience in laboratory services and
business management.
INVESTMENT RATIONALE

Investing in Kronox Lab Sciences’ IPO provides an


opportunity to be part of a growing company with
strong fundamentals and a clear vision for future
growth. The company’s focus on quality and
innovation positions it well to capitalize on
increasing demand for laboratory services.

Kronox Lab Sciences’ IPO presents a promising


investment opportunity given its strong financials,
diversified service offerings, and strategic growth
plans. Potential investors should consider the
company's competitive strengths and weigh them
against the inherent risks before making an
investment decision.
Thank you, to get more information
about this IPO and to apply, message me
today

You might also like